EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

miR-627-5p inhibits malignant progression of cervical cancer by targeting ANGPTL4

Xinghua Wu, Kai Lin, Chen Gao, Yinfang Ni, Li Zhang, Tailai Yang, Jinguo Chen

European Journal of Histochemistry · 2025

DOI: 10.4081/ejh.2025.4161 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Histochemistry, 2025. Verfasst von Xinghua Wu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Ningde Clinical Medical College of Fujian Medical University; Ningde Municipal Hospital of Ningde Normal University, Ningde. Hauptthemen laut MEDLINE: MicroRNAs, Uterine Cervical Neoplasms, Angiopoietin-Like Protein 4. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In recent years, accumulating evidence has highlighted the critical role of miR-627-5p in the occurrence and progression of various cancers. However, its specific role and mechanism in cervical cancer (CC) remain unclear. This study aimed to elucidate the mechanism by which miR-627-5p inhibits the malignant progression of CC and assess its potential clinical implications. In C33A cells, the mRNA expression levels of ANGPTL4 and miR-627-5p were analyzed using qRT-PCR. The miR-627-5p mimics and their control (miR-NC) were transfected into C33A cells to determine whether miR-627-5p directly regulates ANGPTL4 expression. A comprehensive suite of assays, including CCK-8, migration, transwell, flow cytometry, and Western blotting, was conducted to evaluate how miR-627-5p modulates the malignant biological behavior of CC cells. Rescue experiments were performed by overexpressing ANGPTL4. In C33A cells, miR-627-5p expression was reduced, whereas ANGPTL4 expression was elevated. Further analysis confirmed that miR-627-5p negatively regulates ANGPTL4 by directly targeting its 3'-UTR. Functional assays demonstrated that miR-627-5p inhibits proliferation, invasion, migration, and epithelial-mesenchymal transition (EMT) while promoting apoptosis and S-phase arrest in C33A cells, effects that were reversed by ANGPTL4 overexpression. These findings highlight the potential of miR-627-5p as both a biomarker and a therapeutic target for CC. By inhibiting EMT and regulating ANGPTL4 expression, miR-627-5p may provide a novel avenue for improving therapeutic strategies, particularly in advanced or metastatic CC. Moreover, miRNA-based therapies, supported by advanced delivery systems such as nanoparticle carriers, could enhance the stability and precision of miR-627-5p applications. This study lays the groundwork for future research integrating miR-627-5p into precision medicine approaches for CC treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsUterine Cervical NeoplasmsAngiopoietin-Like Protein 4HumansFemaleCell ProliferationCell MovementCell Line, TumorDisease ProgressionGene Expression Regulation, NeoplasticEpithelial-Mesenchymal Transition

Substanzen

MicroRNAsAngiopoietin-Like Protein 4ANGPTL4 protein, human

Autor:innen und Institutionen

  • Ningde Clinical Medical College of Fujian Medical University; Ningde Municipal Hospital of Ningde Normal University, Ningde.
  • Ningde Clinical Medical College of Fujian Medical University; Ningde Municipal Hospital of Ningde Normal University, Ningde, Fujian.
  • Ningde Clinical Medical College of Fujian Medical University; Ningde Maternity and Child Health Hospital, Ningde, Fujian.

Zitieren

APA

Wu, X., Lin, K., Gao, C., Ni, Y., Zhang, L., Yang, T., & Chen, J. (2025). miR-627-5p inhibits malignant progression of cervical cancer by targeting ANGPTL4. European Journal of Histochemistry. https://doi.org/10.4081/ejh.2025.4161

Vancouver

Wu X, Lin K, Gao C, Ni Y, Zhang L, Yang T, et al. miR-627-5p inhibits malignant progression of cervical cancer by targeting ANGPTL4. European Journal of Histochemistry. 2025. doi:10.4081/ejh.2025.4161

BibTeX
@article{Wu2025,
  author = {Wu, Xinghua and Lin, Kai and Gao, Chen and Ni, Yinfang and Zhang, Li and Yang, Tailai and Chen, Jinguo},
  title = {miR-627-5p inhibits malignant progression of cervical cancer by targeting ANGPTL4},
  journal = {European Journal of Histochemistry},
  year = {2025},
  doi = {10.4081/ejh.2025.4161}
}
Kostenlos starten →